liothyronine sodium
- Product NDC
- 60687-625
- 11-digit product format
- 606870625
- Labeler code
- 60687
- Product ID
- 60687-625_d61ad177-a3aa-47ed-e053-2995a90a0688
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- liothyronine sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- American Health Packaging
- Application
- ANDA091382
- Marketing category
- ANDA
- Marketing start
- 2022-01-15
- Marketing end
- 0000-00-00
- Substance
- LIOTHYRONINE SODIUM
- Active strength
- 5 ug/1
- Pharmacologic classes
- Triiodothyronine [CS], l-Triiodothyronine [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| GCA9VV7D2N | LIOTHYRONINE SODIUM | 55-06-1 | LIOTHYRONINE SODIUM |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60687-625-21 | 60687062521 | 30 BLISTER PACK in 1 CARTON (60687-625-21) > 1 TABLET in 1 BLISTER PACK (60687-625-11) | 30 blister pack | 2022-01-15 | 0000-00-00 | No | No | Current |